Discussion about this post

User's avatar
Neural Foundry's avatar

The J&J acquisition of Halda for $3B makes strategic sense given their focus on oncology after the Kenvue spinoff. LeCun's critique of LLMs as a dead end is provocativ, but his world models approach could take years to materialize. The emphasis on quality and reslience stocks in this volatle environment is spot on.

Expand full comment

No posts

Ready for more?